A machine learning regression model for the screening and design of potential SARS-CoV-2 protease inhibitors

The widespread infection caused by the 2019 novel corona virus (SARS-CoV-2) has initiated global efforts to search for antiviral agents. Drug discovery is the first step in the development of commercially viable pharmaceutical products to deal with novel diseases. In an effort to accelerate the scre...

Descripción completa

Detalles Bibliográficos
Autores principales: Janairo, Gabriela Ilona B., Yu, Derrick Ethelbhert C., Janairo, Jose Isagani B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308067/
https://www.ncbi.nlm.nih.gov/pubmed/34336544
http://dx.doi.org/10.1007/s13721-021-00326-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308067/
https://www.ncbi.nlm.nih.gov/pubmed/34336544
http://dx.doi.org/10.1007/s13721-021-00326-2

Ejemplares similares